BackReplimune Group Overview

Replimune Group Research & Development

Research & Development expenses for REPL.

Quarterly R&D Expenses

$53.14M
↑ 10.7% YoY

As of Dec 31, 2025

Annual R&D Expenses (TTM)

$223.88M
↑ 26.8% YoY

Trailing 12 months ending Dec 31, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin